Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Exicure Collaborate with Ipsen to Target Rare Neurodegenerative Disorders
Exicure Inc. (NASDAQ: XCUR) and Ipsen have signed an exclusive collaboration agreement to research, develop and commercialize novel Spherical Nucleic Acid as potential investigational treatments for Huntington’s disease and...